Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
317.02
-2.62 (-0.82%)
May 6, 2025, 4:00 PM EDT - Market closed
Molina Healthcare Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Molina Healthcare stock have an average target of 364.8, with a low estimate of 297 and a high estimate of 414. The average target predicts an increase of 15.07% from the current stock price of 317.02.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Molina Healthcare stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 3 | 3 | 3 | 5 | 5 |
| Hold | 6 | 7 | 6 | 8 | 7 | 9 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 12 | 14 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $339 → $362 | Hold | Maintains | $339 → $362 | +14.19% | Apr 25, 2025 |
| Bernstein | Bernstein | Buy Initiates $414 | Buy | Initiates | $414 | +30.59% | Apr 22, 2025 |
| Baird | Baird | Buy → Hold Downgrades $331 → $375 | Buy → Hold | Downgrades | $331 → $375 | +18.29% | Apr 15, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $340 → $400 | Strong Buy | Maintains | $340 → $400 | +26.18% | Apr 11, 2025 |
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Apr 9, 2025 |
Financial Forecast
Revenue This Year
44.29B
from 39.16B
Increased by 13.10%
Revenue Next Year
47.74B
from 44.29B
Increased by 7.77%
EPS This Year
24.73
from 20.42
Increased by 21.10%
EPS Next Year
28.36
from 24.73
Increased by 14.70%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 46.8B | 51.0B | 54.3B | |
| Avg | 44.3B | 47.7B | 51.0B | |
| Low | 40.9B | 44.0B | 47.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 19.6% | 15.2% | 13.9% | |
| Avg | 13.1% | 7.8% | 6.8% | |
| Low | 4.3% | -0.8% | 0.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 26.00 | 32.55 | 37.38 | |
| Avg | 24.73 | 28.36 | 32.44 | |
| Low | 23.20 | 26.55 | 29.89 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 27.3% | 31.6% | 31.8% | |
| Avg | 21.1% | 14.7% | 14.4% | |
| Low | 13.6% | 7.4% | 5.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.